Latest Articles

Subject

Research Article
More Efficient Complement Activation by Anti–Aquaporin-4 Compared With Anti–Myelin Oligodendrocyte Glycoprotein Antibodies
Magdalena Lerch, Kathrin Schanda, Eliott Lafon, et al.

November 22, 2022
Research Article
Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort
Falk Steffen, Timo Uphaus, Nina Ripfel, et al.

November 21, 2022
Research Article
Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination
Anna G. Francis, Kariem Elhadd, Valentina Camera, et al.

November 21, 2022
Research Article
Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine TabletsA MAGNIFY-MS Substudy
Heinz Wiendl, Klaus Schmierer, Suzanne Hodgkinson, et al.

November 21, 2022
Research Article
Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple Sclerosis
Nicolás Fissolo, Agustin Pappolla, Jordi Rio, et al.

November 21, 2022
Research Article
Sustained Low Relapse Rate With Highly Variable B-Cell Repopulation Dynamics With Extended Rituximab Dosing Intervals in Multiple Sclerosis
Chiara Starvaggi Cucuzza, Elisa Longinetti, Nicolas Ruffin, et al.

November 21, 2022
Research Article
Guillain-Barré Syndrome Following Zika Virus Infection Is Associated With a Diverse Spectrum of Peripheral Nerve Reactive Antibodies
Alexander J. Davies, Cinta Lleixà, Ana M. Siles, et al.

November 21, 2022
Research Article
CD59 Expression in Skeletal Muscles and Its Role in Myasthenia Gravis
Kazuo Iwasa, Yutaka Furukawa, Hiroaki Yoshikawa, et al.

November 17, 2022
Research Article
Longitudinal Postvaccine SARS-CoV-2 Immunoglobulin G Titers, Memory B-Cell Responses, and Risk of COVID-19 in Multiple Sclerosis Over 1 Year
Giulio Disanto, Alice Galante, Marco Cantu', et al.

November 17, 2022
Clinical/Scientific Note
CLIPPERS Responsive to Cladribine as a Durable Steroid-Sparing Agent
Simon Thebault, Hailey Bergman, Harold L. Atkins, et al.

November 17, 2022

Pages